LobbyingCognito Therapeutics lobbying by quarter
Cognito Therapeutics's latest lobbying report covers Q2 2026, at $6,500. The four quarters Q4 2025–Q3 2026 total $6,500. Its first report covers Q3 2025.
Cognito Therapeutics
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $6,500
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q3 2025
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q3 2025 | $0 | 1 |
| Q4 2025 | $0 | 1 |
| Q1 2026 | $0 | 1 |
| Q2 2026 | $6,500 | 1 |
| Q3 2026 | $0 | 0 |
By issue
No issue reported.
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
No house or agency named.
Firms it paid
| Firm | ||
|---|---|---|
| Rubrum Advising | $6,500 | 4 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/21for Q2 | Rubrum Advising | $6,500 |
| 04/20for Q1 | Rubrum Advising | Under $5,000 |
| 01/20for Q4 2025 | Rubrum Advising | Under $5,000 |
| 25/10/20for Q3 2025 | Rubrum Advising | Under $5,000 |
| 25/10/08for Q3 2025 | Rubrum Advising | Under $5,000 |